Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 26, 2024, with respect to the financial statements of Vera Therapeutics, Inc., incorporated herein by reference.
/s/ KPMG LLP
San Francisco, California
March 26, 2024